Obermatt
See Similar Stocks →

Flags

Financial distress

Fortrea

NSQ:FTRE · US34965K1079
Life Sciences Tools & ServicesLarge

360

42
EV / EBIT70
Price / Owner Earnings58
Owner Earnings Yield1
Dividend Yield1
Price/Sales91
EV / Gross Profit83
Price/Book50
Return on Capital42
Cash Return on Capital13
Return on Equity8
EBIT Margin42
Gross Profitability62
Accruals100
Owner Earnings Margin38
Sales growth12
Profit Growth52
Long-Term EPS Growth100
Reinvestment37
Price momentum95
Debt load18
Refinancing7
Debt Payback1
Liquidity44
Analyst ratings25
Opinion Changes42
Price Target Upside7
Market mood1
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Fortrea doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
TypePublic Company
ExchangeNASDAQGS
Founded2023
Employees10,104
Websitefortrea.com
ISINUS34965K1079
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsPharmacovigilanceCentral Nervous SystemBiometricsOncologyArtificial IntelligenceRespiratory

Description

Fortrea Holdings Inc. (Fortrea) is a global contract research organization (‘CRO’), providing biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology and medical device customers. The company provides phas…

Analysis

Middle-of-the-road

Fortrea Holdings Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is solid and the balance sheet is fragile. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
14
2026

All-time high

51

Mar 2026

All-time low

14

Jun 2026

Average rank

33

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
91
—
—
—
Price/Earnings
37
—
—
—
Price/Book
50
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
55
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Fortrea with its peers
Medpaces
NSQ:MEDP
96
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
IQVIA
NYQ:IQV
49
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Inotiv
NAQ:NOTV
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Charles River Laboratories
NYQ:CRL
17
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Cryoport
NAQ:CYRX
83
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →